شحن مجاني إلى جميع أنحاء العالم 10% off orders at 400.00 $+ تصفّح مكتبة شهادات التحليل
Azure Synthetics Azure Synthetics Research peptides, clearly documented.
Hexarelin

أبحاث محور هرمون النمو

Hexarelin

أبحاث محور هرمون النمو | 5mg

Hexarelin is a synthetic GH secretagogue research peptide studied in endocrine and cardiometabolic signaling models.

نطاق السعر: من ⁦42.99 $⁩ خلال ⁦182.99 $⁩
98.5%-99.1% Lyophilized powder 5 mg
Available documentation

Support can confirm any currently available COAs or batch documentation for this product.

اطلب الوثائق المتاحة

For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent disease.

التخزين

Keep sealed, cold, dry, and protected from heat swings. Confirm product-specific storage on arrival.

ملاحظات الشحن

Packed for transit stability with order support available for warm-weather routes.

مرجع الدفعة

Batch-linked certificate support is available through the documentation desk.

سياق البحث

ملف بحث Hexarelin

Hexarelin is a synthetic hexapeptide growth hormone secretagogue studied at the ghrelin receptor. Research includes GH-release response, receptor potency, endocrine markers, desensitization, and experimental cardiac or metabolic signaling observations. It is often compared with GHRP-2, GHRP-6, and ipamorelin to examine differences in potency and selectivity, while GHRH analogs such as sermorelin and CJC-1295 provide a separate receptor pathway for comparison. Hexarelin is most appropriate when a study specifically needs this GHS-R ligand rather than a general GH-axis material. Much of the broader mechanistic evidence is preclinical or early-stage and should remain tied to its original model.

Molecular class

Six-residue GH secretagogue

Sequence / composition

His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2; a modified hexapeptide with non-native stereochemistry.

Research design note

Sequence modifications are central to its potency and mean it should not be treated as a native ghrelin fragment.

الآلية المقترحة

A potent synthetic GHS-R1a agonist that stimulates GH release through pituitary and hypothalamic pathways. Additional cardiac and cytoprotective mechanisms have been proposed in preclinical studies, some potentially independent of GH.

التأثيرات المذكورة في الدراسات

  • Human pharmacology studies reported strong acute GH release and endocrine responses after hexarelin exposure.
  • Animal and cell studies reported changes in cardiac function, survival signaling, fibrosis, and tissue-injury markers.
  • Repeated exposure can cause desensitization, and cardiac findings remain largely preclinical and mechanism dependent.

نقاط القياس البحثية الشائعة

GHS-R potency, GH, ACTH, cortisol, prolactin, receptor desensitization, cardiac contractility, fibrosis, apoptosis, inflammatory markers, and pharmacokinetics.

الأدلة والقيود

Human evidence primarily addresses acute endocrine pharmacology; proposed cardiac effects are largely preclinical and not established as human outcomes.

External reading

الأدبيات للسياق، وليست إثباتًا للمنتج.

Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.

Support and documentation

Questions about this product?

Where can I find product documentation?

Contact support with the product name and any relevant order or batch reference to request available documents.

How can I compare pack options?

Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.